Canopy Life Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Canopy Life Sciences's estimated annual revenue is currently $47M per year.
- Canopy Life Sciences's estimated revenue per employee is $201,000
Employee Data
- Canopy Life Sciences has 234 Employees.
- Canopy Life Sciences grew their employee count by 26% last year.
Canopy Life Sciences's People
Name | Title | Email/Phone |
---|
Canopy Life Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.9M | 114 | 24% | N/A | N/A |
#2 | $1105.9M | 5502 | 3% | N/A | N/A |
#3 | $47M | 234 | 26% | N/A | N/A |
#4 | $9.2M | 46 | 5% | N/A | N/A |
#5 | $10192.5M | 50709 | 3% | N/A | N/A |
#6 | $6M | 30 | 0% | N/A | N/A |
#7 | $110.1M | 548 | 9% | N/A | N/A |
#8 | $8.8M | 44 | -2% | N/A | N/A |
#9 | $21.3M | 106 | -27% | N/A | N/A |
#10 | $27.7M | 138 | -28% | N/A | N/A |
What Is Canopy Life Sciences?
Canopy provides Clinical to Commercial services to 225 Biotechnology, Pharmaceutical and Medical Device Companies. The company partners with clients, delivering on-demand expertise, outsourced services, and technology. Wherever the challenges lie, we help clients navigate past them. The company offers comprehensive solutions in the areas of Regulatory Affairs, Regulatory Operations & Submissions, MLR (Medical, Legal, Regulatory review of Medical and Promotional Materials), Medical Affairs, Technology (Veeva and Infrastructure Support) and Global Recruiting. These solutions are delivered globally with operation centers in North America, Europe, and Asia. For more information on our offerings, visit our website at www.hellocanopy.com and follow our page to stay up to date on the latest Canopy news!
keywords:N/AN/A
Total Funding
234
Number of Employees
$47M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $88.1M | 260 | 6% | N/A |
#2 | $59.2M | 299 | N/A | N/A |
#3 | $97.9M | 373 | 6% | N/A |
#4 | $169.7M | 468 | 4% | N/A |
#5 | $300M | 494 | -7% | $139.4M |